YU42409B - Process for obtaining new pyridine derivatives - Google Patents

Process for obtaining new pyridine derivatives

Info

Publication number
YU42409B
YU42409B YU1507/81A YU150781A YU42409B YU 42409 B YU42409 B YU 42409B YU 1507/81 A YU1507/81 A YU 1507/81A YU 150781 A YU150781 A YU 150781A YU 42409 B YU42409 B YU 42409B
Authority
YU
Yugoslavia
Prior art keywords
pyridine derivatives
obtaining new
new pyridine
obtaining
derivatives
Prior art date
Application number
YU1507/81A
Other languages
English (en)
Other versions
YU150781A (en
Inventor
J E Delarge
C L Lapiere
S H Georges
Original Assignee
Christiaens Sa A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB1683674A priority Critical patent/GB1477664A/en
Priority to ZA00752243A priority patent/ZA752243B/xx
Priority to BE155330A priority patent/BE827844A/xx
Priority to DE19752516025 priority patent/DE2516025A1/de
Priority to ES436581A priority patent/ES436581A1/es
Priority to HU75CI00001569A priority patent/HU171420B/hu
Priority to IL47084A priority patent/IL47084A/xx
Priority to LU72284A priority patent/LU72284A1/xx
Priority to FR7511791A priority patent/FR2267775B1/fr
Priority to CA224,805A priority patent/CA1070313A/en
Priority to US05/568,759 priority patent/US4018929A/en
Priority to CH216478A priority patent/CH612424A5/xx
Priority to CH216378A priority patent/CH610890A5/xx
Priority to NLAANVRAGE7504521,A priority patent/NL183580C/xx
Priority to CH485775A priority patent/CH609045A5/xx
Priority to MX755155U priority patent/MX4679E/es
Priority to AT189877A priority patent/AT345832B/de
Priority to AT288275A priority patent/AT344170B/de
Priority to SE7504409A priority patent/SE424320B/sv
Priority to JP50047371A priority patent/JPS5951536B2/ja
Priority to AR258409A priority patent/AR211097A1/es
Priority to DD185508A priority patent/DD121936A5/xx
Priority to DD194800A priority patent/DD126887A5/xx
Priority to AU80016/75A priority patent/AU493262B2/en
Priority to AR262627A priority patent/AR208770A1/es
Priority to AR262626A priority patent/AR208769A1/es
Priority to AR262625A priority patent/AR208768A1/es
Priority to US05/694,421 priority patent/US4055650A/en
Priority to ES453329A priority patent/ES453329A1/es
Priority to ES453327A priority patent/ES453327A1/es
Priority to ES453328A priority patent/ES453328A1/es
Priority to AT189777A priority patent/AT344174B/de
Priority to AT189977A priority patent/AT344175B/de
Priority to SE7907618A priority patent/SE7907618L/sv
Priority to US06/119,601 priority patent/USRE30633E/en
Application filed by Christiaens Sa A filed Critical Christiaens Sa A
Priority to YU1507/81A priority patent/YU42409B/xx
Publication of YU150781A publication Critical patent/YU150781A/xx
Publication of YU42409B publication Critical patent/YU42409B/xx
Priority to LU88346C priority patent/LU88346I2/fr
Priority to NL940014C priority patent/NL940014I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
YU1507/81A 1974-04-17 1981-06-15 Process for obtaining new pyridine derivatives YU42409B (en)

Priority Applications (38)

Application Number Priority Date Filing Date Title
GB1683674A GB1477664A (en) 1974-04-17 1974-04-17 Pyridine derivatives
ZA00752243A ZA752243B (en) 1974-04-17 1975-04-08 New derivatives of pyridine
BE155330A BE827844A (fr) 1974-04-17 1975-04-11 Nouveaux derives de la pyridine, leur preparation et leur utilisations
DE19752516025 DE2516025A1 (de) 1974-04-17 1975-04-12 Neue pyridinderivate, ihre herstellung und verwendung
HU75CI00001569A HU171420B (hu) 1974-04-17 1975-04-14 Sposob poluchenija proizvodnykh sul'fonamido-piridina i piridin-tiadiazina
IL47084A IL47084A (en) 1974-04-17 1975-04-14 Substituted 3-carbonly(or thiocarbonyl)amino sulfonyl pyridines
ES436581A ES436581A1 (es) 1974-04-17 1975-04-14 Procedimiento para preparar derivados de piridina.
LU72284A LU72284A1 (sv) 1974-04-17 1975-04-15
CA224,805A CA1070313A (en) 1974-04-17 1975-04-16 Derivatives of pyridine
US05/568,759 US4018929A (en) 1974-04-17 1975-04-16 3-Loweralkylcarbamylsulfonamido-4-phenylaminopyridine-N-oxides, derivatives thereof and pharmaceutical compositions containing same
CH216478A CH612424A5 (sv) 1974-04-17 1975-04-16
CH216378A CH610890A5 (sv) 1974-04-17 1975-04-16
NLAANVRAGE7504521,A NL183580C (nl) 1974-04-17 1975-04-16 Werkwijze voor de bereiding van een geneesmiddel met diuretische en anti-inflammatoire werking, aldus verkrijgbaar therapeutisch voorwerp, en werkwijze voor het bereiden van daarin te gebruiken 3-sulfamoylpyridine-derivaten.
CH485775A CH609045A5 (sv) 1974-04-17 1975-04-16
MX755155U MX4679E (es) 1974-04-17 1975-04-16 Procedimiento para preparar derivados de piridina
AT189877A AT345832B (de) 1974-04-17 1975-04-16 Verfahren zur herstellung neuer pyridinderivate und ihrer salze
AT288275A AT344170B (de) 1974-04-17 1975-04-16 Verfahren zur herstellung neuer pyridinderivate und ihrer n-oxide und salze
SE7504409A SE424320B (sv) 1974-04-17 1975-04-16 Analogiforfarande for framstellning av derivat av 3-sulfonamido-4-amino-pyridiner
FR7511791A FR2267775B1 (sv) 1974-04-17 1975-04-16
JP50047371A JPS5951536B2 (ja) 1974-04-17 1975-04-17 ピリジン誘導体の製法
AR258409A AR211097A1 (es) 1974-04-17 1975-04-17 Procedimiento para la preparacionde nuevos derivados de 3-(carbamil o tiocarbamil)-sulfamido-piridina-4-sustituida.
DD185508A DD121936A5 (sv) 1974-04-17 1975-04-17
DD194800A DD126887A5 (sv) 1974-04-17 1975-04-17
AU80016/75A AU493262B2 (en) 1974-04-17 1975-04-18 New derivatives of pyridine
AR262627A AR208770A1 (es) 1974-04-17 1976-03-19 Un procedimiento para preparar nuevos derivados de la 3(acilsulfonamido)-piridina-4-sustituida
AR262626A AR208769A1 (es) 1974-04-17 1976-03-19 Un procedimiento para preparar nuevos derivados de la 3-sulfonamido-piridina
AR262625A AR208768A1 (es) 1974-04-17 1976-03-19 Un procedimiento para preparar nuevos derivados de la 4-amino-3-sulfonamido-piridina
US05/694,421 US4055650A (en) 1974-04-17 1976-06-09 Certain 4-phenoxy(or phenylthio)-3-n-acylated-sulfonamido-pyridines
ES453327A ES453327A1 (es) 1974-04-17 1976-11-15 Metodo de obtencion de derivados de piridina.
ES453329A ES453329A1 (es) 1974-04-17 1976-11-15 Metodo de preparar derivados de piridina.
ES453328A ES453328A1 (es) 1974-04-17 1976-11-15 Procedimiento para preparar derivados de piridina.
AT189777A AT344174B (de) 1974-04-17 1977-03-18 Verfahren zur herstellung neuer pyridinderivate und ihrer salze
AT189977A AT344175B (de) 1974-04-17 1977-03-18 Verfahren zur herstellung neuer pyridinderivate und ihrer salze
SE7907618A SE7907618L (sv) 1974-04-17 1979-09-13 Sett att framstella nya pyridinderivat och anvendning derav som lekemedel
US06/119,601 USRE30633E (en) 1974-04-17 1980-02-07 3-Lower alkylcarbamylsulfonamido-4-phenylaminopyridines, n-oxides, derivatives thereof and pharmaceutical compositions containing same
YU1507/81A YU42409B (en) 1974-04-17 1981-06-15 Process for obtaining new pyridine derivatives
LU88346C LU88346I2 (fr) 1974-04-17 1993-06-30 Torasemide (Exhydran)
NL940014C NL940014I2 (nl) 1974-04-17 1994-07-27 Werkwijze voor de bereiding van een geneesmiddel met diuretische en anti-inflammatoire werking, aldus verkrijgbaar therapeutisch voorwerp, en werkwijze voor het bereidenvan daarin te gebruiken 3-sulfamoylpyridine-derivaten.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1683674A GB1477664A (en) 1974-04-17 1974-04-17 Pyridine derivatives
YU1507/81A YU42409B (en) 1974-04-17 1981-06-15 Process for obtaining new pyridine derivatives

Publications (2)

Publication Number Publication Date
YU150781A YU150781A (en) 1984-02-29
YU42409B true YU42409B (en) 1988-08-31

Family

ID=26252269

Family Applications (1)

Application Number Title Priority Date Filing Date
YU1507/81A YU42409B (en) 1974-04-17 1981-06-15 Process for obtaining new pyridine derivatives

Country Status (19)

Country Link
US (2) US4018929A (sv)
JP (1) JPS5951536B2 (sv)
AR (4) AR211097A1 (sv)
AT (1) AT344170B (sv)
BE (1) BE827844A (sv)
CA (1) CA1070313A (sv)
CH (3) CH612424A5 (sv)
DD (2) DD126887A5 (sv)
DE (1) DE2516025A1 (sv)
ES (4) ES436581A1 (sv)
FR (1) FR2267775B1 (sv)
GB (1) GB1477664A (sv)
HU (1) HU171420B (sv)
IL (1) IL47084A (sv)
LU (2) LU72284A1 (sv)
NL (2) NL183580C (sv)
SE (2) SE424320B (sv)
YU (1) YU42409B (sv)
ZA (1) ZA752243B (sv)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593609A (en) * 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
US4776878A (en) * 1978-12-04 1988-10-11 E. I. Du Pont De Nemours And Company Agricultural pyridinesulfonamides
LU85193A1 (fr) * 1984-01-31 1985-09-12 Christiaens Sa A Nouveaux derives de la 4-phenylaminopyridine,leur utilisation et leur preparation
DE3529529A1 (de) * 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid
US4914203A (en) * 1987-07-24 1990-04-03 American Home Products Corporation 5 step process for preparing certain 2,4-diamino-5-pyrimidine-sulfonyl ureas
US4853389A (en) * 1987-07-24 1989-08-01 American Home Products Corporation Diuretic and antihypertensive substituted-5-pyrimidinesulfonylureas
FR2659080B1 (fr) * 1990-03-02 1994-07-08 Adir Nouveaux derives de la pyridylsulfonyluree et de la pyridylsulfonylthiouree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5166162A (en) * 1990-03-02 1992-11-24 Adir Et Compagnie Pyridylsulfonylurea and pyridylsulfonylthiourea compounds
US5486530A (en) * 1991-04-27 1996-01-23 Boehringer Mannheim Gmbh Use of torasemide for the treatment of brain oedemas
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
HRP980532B1 (en) * 1998-10-02 2005-06-30 Pliva Novel crystalline torasemide modification
US6166045A (en) * 1998-06-02 2000-12-26 Roche Diagnostics Gmbh Torasemide of modification III
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
CA2379322A1 (en) * 1999-08-11 2001-02-15 Teva Pharmaceutical Industries Ltd. Torsemide polymorphs
SK11632003A3 (sk) * 2000-02-17 2004-04-06 Teva Pharmaceutical Industries Ltd. Stabilný farmaceutický prípravok obsahujúci modifikáciu II torsemidu
HRP20000162B1 (en) 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
EP1741429A3 (en) * 2000-03-20 2007-01-17 Teva Pharmaceutical Industries Ltd. Processes for preparing torsemide
CA2403382A1 (en) * 2000-03-20 2001-09-27 Teva Pharmaceutical Industries Ltd. Novel processes for preparing torsemide intermediate
HRP20000328A2 (en) 2000-05-19 2002-02-28 Pliva Farmaceutska Ind Dionik Novel polymorph v of torasemide
US20030022921A1 (en) * 2001-02-21 2003-01-30 Minutza Leibovici Stable pharmaceutical formulation comprising torsemide modification II
IN192178B (sv) 2001-08-03 2004-03-06 Ranbaxy Lab
IL149771A0 (en) * 2002-05-21 2002-11-10 Fintech Lab Ltd Process for preparation of torsemide
HRP20020603B1 (en) * 2002-07-19 2008-11-30 Pliva D.D. New process for the preparation of modification i n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
CA2401546C (en) * 2002-09-06 2006-09-19 Brantford Chemicals Inc. Preparation of derivatives of 3-sulfonamido-4-phenylaminopyridine
ITMI20022749A1 (it) * 2002-12-23 2004-06-24 Cosma S P A Nuovo procedimento per la sintesi della tosemide, in particolare della forma ii pura e stabile.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20050215600A1 (en) * 2003-10-27 2005-09-29 Arie Gutman Polymorphs of torsemide hydrochloride and process for production thereof
US7378527B2 (en) * 2004-03-16 2008-05-27 Daqing Che Process for the preparation of torsemide and related intermediates
US20070149526A1 (en) * 2005-10-17 2007-06-28 Neurotherapeutics Pharma, L.L.C. Diuretic and diuretic-like compound analogs
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7625896B2 (en) * 2005-11-25 2009-12-01 Hoffman-La Roche Inc. Pyridylsulfonamide derivatives
US7939532B2 (en) * 2006-10-26 2011-05-10 Hoffmann-La Roche Inc. Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
CN101675033A (zh) * 2007-05-16 2010-03-17 霍夫曼-拉罗奇有限公司 芳基吡啶基磺酰胺衍生物，它们的制备和作为药剂的应用
NL2006622C2 (en) 2011-04-18 2012-10-22 Eurovet Animal Health B V Use of a composition comprising torasemide.
WO2014014519A1 (en) 2012-07-20 2014-01-23 University Of Rochester Method of treating and preventing brain impairment using na+-k+ -2ci- cotransporter isoform 1 inhibitors
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
EP3578547B1 (en) * 2015-02-16 2021-05-26 The University of Queensland Sulfonylureas and related compounds and use of same
WO2019008025A1 (en) 2017-07-07 2019-01-10 Inflazome Limited NOVEL CARBOXAMIDE SULFONAMIDE COMPOUNDS
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674794A (en) * 1970-03-18 1972-07-04 Ciba Geigy Corp Certain-3-pyridine-sulfonamide derivatives
GB1368948A (en) * 1970-11-11 1974-10-02 Manuf Prod Pharma Pyridine derivatives
GB1414793A (en) * 1972-07-28 1975-11-19 Manuf Prod Pharma Derivatives of phenylaminopyridine
US3904636A (en) * 1971-11-09 1975-09-09 Christiaens Sa A 3-sulfonamido-4-phenyl aminopyridines and derivatives

Also Published As

Publication number Publication date
NL7504521A (nl) 1975-10-21
AR211097A1 (es) 1977-10-31
NL183580C (nl) 1988-12-01
ES436581A1 (es) 1977-04-01
DE2516025C2 (sv) 1988-11-03
CH612424A5 (sv) 1979-07-31
HU171420B (hu) 1978-01-28
LU88346I2 (fr) 1994-05-04
ZA752243B (en) 1976-03-31
ES453329A1 (es) 1977-11-16
ES453328A1 (es) 1977-11-01
SE7907618L (sv) 1979-09-13
DD126887A5 (sv) 1977-08-17
JPS5951536B2 (ja) 1984-12-14
NL940014I2 (nl) 1997-04-01
AT344170B (de) 1978-07-10
CH609045A5 (sv) 1979-02-15
NL940014I1 (nl) 1994-09-16
ATA288275A (de) 1977-11-15
AR208770A1 (es) 1977-02-28
USRE30633E (en) 1981-06-02
AR208769A1 (es) 1977-02-28
SE7504409L (sv) 1975-10-20
CA1070313A (en) 1980-01-22
SE424320B (sv) 1982-07-12
DD121936A5 (sv) 1976-09-05
AR208768A1 (es) 1977-02-28
YU150781A (en) 1984-02-29
FR2267775A1 (sv) 1975-11-14
AU8001675A (en) 1976-10-14
DE2516025A1 (de) 1975-11-06
GB1477664A (en) 1977-06-22
NL183580B (nl) 1988-07-01
ES453327A1 (es) 1977-11-16
FR2267775B1 (sv) 1978-11-10
BE827844A (fr) 1975-10-13
IL47084A (en) 1979-01-31
US4018929A (en) 1977-04-19
CH610890A5 (sv) 1979-05-15
JPS50142571A (sv) 1975-11-17
IL47084A0 (en) 1975-06-25
LU72284A1 (sv) 1975-08-20

Similar Documents

Publication Publication Date Title
YU42409B (en) Process for obtaining new pyridine derivatives
HU173590B (hu) Sposob poluchenija proizvodnykh d-6-metil-8-tiometil-ehrgolina
HU173739B (hu) Sposob poluchenija proizvodnykh tienotiazina
YU56075A (en) Process for obtaining new 2-arylamino-2-imidazoline derivatives
HU172431B (hu) Sposob poluchenija proizvodnykh fenola
YU39967B (en) Process for obtaining new pyridine derivatives
HU172493B (hu) Sposob poluchenija proizvodnykh tienobenzodiazepina
YU76681A (en) Process for obtaining new thiaprostaglandin derivatives
HU173609B (hu) Sposob poluchenija novykh proizvodnykh salicilanilida
HU173740B (hu) Sposob poluchenija proizvodnykh aza-digidro-prostaglandina
HU172146B (hu) Sposob poluchenija proizvodnykh cinnolina
HU174300B (hu) Sposob poluchenija proizvodnykh 1-acil-4-/o-galofenil/-tiosemikarbazida
YU293975A (en) Process for obtaining phenylpyridylamine derivatives
HU173890B (hu) Sposob poluchenija novykh proizvodnykh n-butil-amina
YU40449B (en) Process for obtaining new dianhydrodulcite derivatives
YU157375A (en) Process for preparing new ergopetine derivatives
YU37350B (en) Process for obtaining new benzhydryloxy-alkylamine derivatives
YU162075A (en) Process for obtaining new thieno-pyridine derivatives
YU35891B (en) Process for obtaining 3-cephem-3-sulfonate derivatives
YU52675A (en) Process for obraining dibenzocycloheptapyrrol derivatives
YU284875A (en) Process for obtaining new isoquinoline derivatives
YU122575A (en) Process for obtaining ecetoxime derivatives
YU39737B (en) Process for obtaining new pyridine derivatives
HU171987B (hu) Novyjj sposob poluchenija proizvodnykh 11-beta-gidroksi-18-metilestrana
YU36702B (en) Process for obtaining pyridine derivatives